Email Page Print Page

SEC Filings and Financial Information

Select the filing type and date range you wish to view from the drop-down menus below.

NASDAQBDSI
FormDescriptionDateFormat
10QSBQuarterly report filed by small businessesNov 14, 2001View HTMLDownload DOCDownload PDFDownload XLS
SB-2/APre-effective amendment to an SB-2 filingNov 9, 2001View HTMLDownload DOCDownload PDFDownload XLS
SB-2Optional form for the registration of securities to be sold to the public by small business issuersNov 7, 2001View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventOct 26, 2001View HTMLDownload DOCDownload PDFDownload XLS
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Sep 25, 2001View HTMLDownload DOCDownload PDFDownload XLS
PRE 14AA preliminary proxy statement providing notification matters to be brought to a voteSep 6, 2001View HTMLDownload DOCDownload PDFDownload XLS
10QSBQuarterly report filed by small businessesAug 20, 2001View HTMLDownload DOCDownload PDFDownload XLS
10QSBQuarterly report filed by small businessesAug 20, 2001View HTMLDownload DOCDownload PDFDownload XLS
10KSBAnnual report filed by small businessesAug 15, 2001View HTMLDownload DOCDownload PDFDownload XLS
NT 10-QNotification that form type 10-Q will be submitted lateAug 15, 2001View HTMLDownload DOCDownload PDF
NT 10-KNotification that form 10-K will be submitted lateApr 3, 2001View HTMLDownload DOCDownload PDF
8-K/AAmendment to a previously filed 8-KJan 25, 2001View HTMLDownload DOCDownload PDFDownload XLS
Top News
Oct 12, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that it has entered into a...

Oct 6, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) participated in a round table meeting convened this week in Washington, D.C. by the U.S. Department of Health and Human Services (HHS) to...

Sep 19, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, Vice Chairman, President and Chief Executive Officer, will present at two upcoming healthcare conferences....

investor inquiries

 

Al Medwar
Senior Vice President, Corporate and Business Development
BioDelivery Sciences International, Inc.
919-582-9050
amedwar@bdsi.com